SF1126
- Generic Name
- SF1126
- Drug Type
- Small Molecule
- Unique Ingredient Identifier
- DL0Q912033
Overview
SF1126 is an integrin-targeted PI3 kinase inhibitor.
Background
SF1126 is an integrin-targeted PI3 kinase inhibitor.
Indication
For the treatment of various forms of cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath